Page 59 - Read Online
P. 59

Page 2 of 15                Troncone et al. Vessel Plus 2023;7:14  https://dx.doi.org/10.20517/2574-1209.2023.08

               and morbidity including spinal cord ischemia, cardiac, pulmonary, and neurologic events, respiratory
                                                              [3]
               compromise, and renal dysfunction remain significant . Inherent in the conduct of open repair of DTA/
               TAAA is a period during which there is regional ischemia to the visceral organs; and most of the variability
                                                                                             [4]
               between surgical technique lies in the method selected to provide organ protection . The rate of
               renovisceral organ dysfunction after DTA and TAAA repair is widely reported in the literature, depending
               on the clinical and biochemical criteria used to define each, however it ranges from 21%-63% . Other organ
                                                                                             [5]
               systems are affected by periods of ischemia, notably the spinal cord; rates of spinal cord injury, both
               temporary and permanent, have been reported as high as 20% for open repair of DTA/TAAA, with the
               caveat that these rates are most affected by the extent of repair . While it is difficult to ascertain the true
                                                                     [6]
               value due to the heterogeneity of disease extent, indication for surgery, replacement techniques, adjunctive
               protection strategies, and the potential for improved outcomes from experiences centres, mortality rates
               typically range from 5 to 33% .Pertinent to the discussion on the use of deep hypothermic circulatory arrest
                                        [7]
               in the repair of DTA and TAAAs is the specific considerations of aortic cross-clamping. Fundamentally, the
               application of an aortic cross-clamp leads to hemodynamic sequelae proximal to the clamp, and ischemic
               sequelae distal to the clamp, as well as potential clamp-related complications such as vascular trauma,
               iatrogenic aortic dissection, and atheroembolism. Surgical techniques aimed at organ protection primarily
               seek to reduce the impact of distal ischemia imposed on the body by the application of an aortic cross-
               clamp, the most intuitive approach being the continuation of blood perfusion to these organs despite the
               interruption of native blood flow. This is accomplished by the utilization of either left-heart bypass (LHB)
               or cardiopulmonary bypass (CPB), employing various cannulation strategies aimed at the maintenance of
               perfusion distal to the aortic cross-clamp.

               The rationale for using DHCA in TAAA repair are heavily calcified and non-clampable distal aortic arch or
               proximal descending thoracic aorta which include massive aneurysms with distorted anatomy or the need
               to fenestrate a dissection flap in the aortic arch be facilitated by open endoluminal aortic exposure. To
               facilitate overcoming these challenges for aortic replacement for DTAs and TAAAs is the use of CPB with
               DHCA. Defined as the achievement of systemic temperatures between 18-24 degrees Celsius accomplished
               using cardiopulmonary bypass, it facilitates cerebral, cardiac and organ protection during operations
               necessitating cessation of systemic circulation.


               An assessment of the literature on techniques for DTA/TAAA repair reveals some selection criteria
               regarding the use of DHCA.  In summary, the main identifiable criteria that support the use of DHCA
               include severe aortic atherosclerosis which would increase embolic risk with clamping, contained arch
               aneurysm rupture, as well as a porcelain aorta that precludes cross-clamping. Other potential factors may
               include elevated risk of spinal cord ischemia as well as reduced preoperative renal function, as DHCA may
               provide superior spinal cord and visceral organ protection than other perfusion adjuncts at higher patient
                          [8]
               temperatures . Additional factors to consider are if the patient has had prior central aortic procedures
               performed, as the re-operative tissue may increase risk of injury to adjacent structures such as the
               esophagus, bronchus, pulmonary arteries, and left recurrent laryngeal nerve . Furthermore, clamp-induced
                                                                               [9]
               aortic injury, retrograde aortic dissection from clamping, as well as massive, uncontrollable bleeding would
               necessitate the use of DHCA. Beyond these, there are few clinical or patient factors reported for the
               selection of DHCA use for these complex repairs. Pre-operatively identified reduced left ventricular ejection
               fraction, as well as aortic valve insufficiency, may be negative predictive factors for utilizing DHCA. This is
               due to multiple risks associated with using DHCA for DTA/TAAA repair: inadequate myocardial
               protection during hypothermic fibrillatory arrest, hypothermic tissue damage and consequent myocardial
               edema, prolonged CPB times because of cooling and re-warming and left ventricular distention which may
                                                  [8]
               be because of aortic valve insufficiency . Various adjuncts can be used to monitor and avoid these
   54   55   56   57   58   59   60   61   62   63   64